​Just as the disease is unique for each person, so is the tracking of quality of life. Join us to learn about how to create a tool that works for you to track quality of life and disease impact. We will also talk about how to use this tool to more effectively communicate with your […]
EGPA now has a second treatment! Fasenra was approved in the fall of 2024 for EGPA and brings a new take on addressing the issues. Join this livestream to learn about the dual impact: IL-5 unique action and activating natural killer cells.Â
Join us for a conversation about how to effectively communicate and build a relationship with your healthcare provider. You will have an opportunity to watch a conversation unfolding with a patient with ANCA Vasculitis and a healthcare provider. Then, we will sort through barriers and tools to break down the barriers.
Get regular updates to your inbox.
